Legal Solutions
by Shawn Meehan, Global Head of Legal Solutions at Guidepoint Several years ago, the Harvard Business Review set forth a three-pronged test for defining experts as capable of consistently performing superior to one’s peers, producing concrete results, and demonstrating outcomes that could be replicated and measured. If you are competing in sports, think LeBron […]
Read More
by Allison Vickers In cases of medical malpractice, patient harm results from an exercised substandard quality of care. In contrast, medical maloccurrence is defined as one or more adverse outcomes during a medical procedure that are unrelated to the quality of care. To assist judges and jurors in distinguishing whether a case is an example […]
Read More
by Shawn Meehan, Global Head of Legal Solutions at Guidepoint How soon will artificial intelligence transform health care? The U.S. Food & Drug Administration (FDA) seeks to answer that question over the coming months. The implications for patients, doctors, medical device manufacturers, and lawyers could be significant. Earlier this year, the FDA issued a […]
Read More
by Gary Chodes, Litigation Finance Industry Pioneer and founder of industry leaders Oasis, Courthouse Investments and Signal Funding We are now seeing substantial litigation financing activity involving brand name hedge funds players as well as publicly-traded closed-end funds and business development companies (”BDCs”). Activist investors and boards of directors may now use (or be exposed […]
Read More
by Andrew S. Pollis, Professor, Case Western Reserve University School of Law We now have the long-awaited result in the Oklahoma trial against Johnson & Johnson (J&J). While the State of Oklahoma convinced the trial judge that J&J engaged in a public nuisance and that it must now pay $572 million to abate, the amount […]
Read More